CymaBay Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and providing therapies to treat liver and other chronic diseases. Its lead product candidate is seladelpar (MBX-8025), a selective agonist of peroxisome proliferator activated receptor delta that is in phase III clinical study for the treatments of primary biliary cholangitis (PBC), as well as has completed Phase 2b clinical study to treat patients with nonalcoholic steatohepatitis. The company also develops MBX-2982, which is in Phase 2a clinical study for the disease/condition of hypoglycemia in type 1 diabetics. It has a license agreement with ABW Cyclops SPV LP to support development of seladelpar for the treatment of PBC; and holds a worldwide license from Janssen Pharmaceuticals, Inc. to research, develop, and commercialize compounds with activity against an undisclosed metabolic disease target. The company was formerly known as Metabolex, Inc. CymaBay Therapeutics, Inc. was incorporated in 1988 and is headquartered in Newark, California. The 2025 version of the report offers detailed insights into the company's strategies, developments, outlook and drivers. In addition to SWOT Analysis and Financial Overview, the report analyzes key projects, business description, products, services, brands, operating locations, subsidiaries and affiliates of CymaBay Therapeutics Inc..
CymaBay Therapeutics Inc. business operations across the value chain are included. Further, all major operating and planned locations, related contacts, details of subsidiaries and partnerships of CymaBay Therapeutics Inc. are also analyzed.
Detailed SWOT Analysis of the company including key strengths and weaknesses of CymaBay Therapeutics Inc. , on which it can build its business along with potential opportunities and threats in the near to medium term future are detailed.
Key employees of the company including the management team and board of directors are listed with their designations. Further, statistics on key parameters such as employee count, organization structure etc is provided.
Financial analysis of CymaBay Therapeutics Inc. including key ratios, income statement, cash flow statement and balance sheet are provided for the company. In addition, Key historical events, summary analysis of CymaBay Therapeutics Inc. and all latest updates of the company are provided.
The 2025 version of CymaBay Therapeutics Inc. report is presented after intensive primary and secondary research processes and it presents the insights in a complete impartial and reader friendly format.
TABLE OF CONTENTS
1.1 List of Tables
1.2 List of Figures
2 Introduction to the Company
2.1 CymaBay Therapeutics Inc.- Key Facts
2.2 CymaBay Therapeutics Inc.- Geographic Locations
2.3 CymaBay Therapeutics Inc.- Subsidiaries and Affiliates
2.4 CymaBay Therapeutics Inc.- Business Divisions
2.5 CymaBay Therapeutics Inc.- Key Employees
2.5.1 Management Team
2.5.2 Board of Directors
3. CymaBay Therapeutics Inc. Strategic Analysis Review
3.1 CymaBay Therapeutics Inc.- Key Strategies
3.2 CymaBay Therapeutics Inc.- Company Outlook Statement
3.3 CymaBay Therapeutics Inc.- SWOT Analysis
3.3.1 CymaBay Therapeutics Inc.- Key Strengths
3.3.2 CymaBay Therapeutics Inc.- Key Weaknesses
3.3.3 CymaBay Therapeutics Inc.- Potential Opportunities
3.3.4 CymaBay Therapeutics Inc.- Potential Threats
3.4 CymaBay Therapeutics Inc.- Key Competitors
4. Business Description of the Company
4.1 CymaBay Therapeutics Inc.- Business Overview
4.2 CymaBay Therapeutics Inc.- Operations by Segment
5 Products and Services Details
5.1 CymaBay Therapeutics Inc.- Key Products
5.2 CymaBay Therapeutics Inc.- Key Service Areas
5.3 CymaBay Therapeutics Inc.- Key Brands
6 Company Developments
6.1 CymaBay Therapeutics Inc.- Company History
6.2 CymaBay Therapeutics Inc.- Latest Developments
7 Financial Analysis
7.1 CymaBay Therapeutics Inc.- Income Statements
7.2 CymaBay Therapeutics Inc.- Balance Sheet
7.3 CymaBay Therapeutics Inc.- Cash Flow Statements
8 Competitors and Industry Analysis
8.1 CymaBay Therapeutics Inc.- Direct Competitors
8.2 CymaBay Therapeutics Inc.- Competitor Financial Ratios comparison
8.3 CymaBay Therapeutics Inc.- Competitor Stock Charts Comparison
8.4 CymaBay Therapeutics Inc.- Industry Analysis
9 Appendix
9.1 About SWOTreports
9.2 Sources and Methodology
9.3 Contact Information
P.S.Financial Analysis will be provided only for companies reporting financial data.
Get Free Sample
At SWOT Reports, we understand the importance of informed decision-making in today's dynamic business landscape. To help you experience the depth and quality of our market research reports, we offer complimentary samples tailored to your specific needs.
Start Now! Please fill the form below for your free sample.
Why Request a Free Sample?
Evaluate Our Expertise: Our reports are crafted by industry experts and seasoned analysts. Requesting a sample allows you to assess the depth of research and the caliber of insights we provide.
Tailored to Your Needs: Let us know your industry, market segment, or specific topic of interest. Our free samples are customized to ensure relevance to your business objectives.
Witness Actionable Insights: See firsthand how our reports go beyond data, offering actionable insights and strategic recommendations that can drive your business forward.
Embark on your journey towards strategic decision-making by requesting a free sample from SWOT Reports. Experience the caliber of insights that can transform the way you approach your business challenges.
FAQ's
Gain valuable insights into the company for academic or business research purposes with this comprehensive profile. Key elements, such as SWOT analysis and corporate strategy, are included to support your research needs effectively.
Customer and Supplier Identification: Analyze the company’s business structure, operations, major products, services, and strategies to identify potential customers and suppliers.
Leverage a detailed SWOT analysis to understand and evaluate your competitors' business structures, strategies, and core performance metrics. This analysis offers an up-to-date and objective perspective on the company’s strengths, weaknesses, opportunities, and threats.
Didn’t find what you’re looking for? TALK TO OUR ANALYST TEAM
Need something within your budget? NO WORRIES! WE GOT YOU COVERED!
Reach Out to Us
Industries
Resources
Company
Sign up for Offers & Promotions
- Connect with us
- +91 630 95 25755
- sales@swotreports.com
-
Chat on WhatsApp
